Terms: = Thyroid cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Prognosis
10 results:
1. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
2. ER+/PR- phenotype exhibits more aggressive biological features and worse outcome compared with ER+/PR+ phenotype in HER2-negative inflammatory breast cancer.
Luo Y; Li Q; Fang J; Pan C; Zhang L; Xu X; Qian S; Zhao X; Hou L
Sci Rep; 2024 Jan; 14(1):197. PubMed ID: 38167641
[TBL] [Abstract] [Full Text] [Related]
3. [Effects of adjuvant trastuzumab on long-term survival of T1N0M0 stage human epidermal growth factor receptor 2 positive breast cancer: a real-world study].
Sun TH; Lu ZN; Song HT; Sun G
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):101-107. PubMed ID: 36709127
[No Abstract] [Full Text] [Related]
4. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
Wang L; Yao B; Yang J; Tian Z; He J
BMC Cancer; 2022 Nov; 22(1):1131. PubMed ID: 36333684
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 "SLC34A2" in Papillary thyroid Carcinoma: An Immunohistochemical Study.
Hakim SA; Abd El Atti RM; Faheim RM; Abou Gabal HH
Anal Cell Pathol (Amst); 2021; 2021():3198555. PubMed ID: 34336552
[TBL] [Abstract] [Full Text] [Related]
6. Circulating tumour cells as prognosis predictive markers of neoadjuvant chemotherapy-treated breast cancer patients.
Cui Z; Su F; Li Y; Yang D
J Chemother; 2020 Oct; 32(6):304-309. PubMed ID: 32500819
[TBL] [Abstract] [Full Text] [Related]
7. In Silico Analysis Identifies Differently Expressed lncRNAs as Novel Biomarkers for the prognosis of thyroid cancer.
Rao Y; Liu H; Yan X; Wang J
Comput Math Methods Med; 2020; 2020():3651051. PubMed ID: 32377223
[TBL] [Abstract] [Full Text] [Related]
8. Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes.
Tang J; Kong D; Cui Q; Wang K; Zhang D; Liao X; Gong Y; Wu G
World J Surg Oncol; 2018 Mar; 16(1):45. PubMed ID: 29506526
[TBL] [Abstract] [Full Text] [Related]
9. prognosis of small thyroid cancer in patients with Graves' disease.
Kikuchi S; Noguchi S; Yamashita H; Uchino S; Kawamoto H
Br J Surg; 2006 Apr; 93(4):434-9. PubMed ID: 16523447
[TBL] [Abstract] [Full Text] [Related]
10. Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995.
Farahati J; Geling M; Mäder U; Mörtl M; Luster M; Müller JG; Flentje M; Reiners C
Thyroid; 2004 Feb; 14(2):141-7. PubMed ID: 15068629
[TBL] [Abstract] [Full Text] [Related]
